1. Home
  2. AGX vs AMRX Comparison

AGX vs AMRX Comparison

Compare AGX & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGX
  • AMRX
  • Stock Information
  • Founded
  • AGX 1961
  • AMRX 2002
  • Country
  • AGX United States
  • AMRX United States
  • Employees
  • AGX N/A
  • AMRX N/A
  • Industry
  • AGX Engineering & Construction
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGX Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • AGX Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • AGX 3.0B
  • AMRX 2.5B
  • IPO Year
  • AGX N/A
  • AMRX N/A
  • Fundamental
  • Price
  • AGX $223.88
  • AMRX $9.45
  • Analyst Decision
  • AGX Buy
  • AMRX Strong Buy
  • Analyst Count
  • AGX 3
  • AMRX 4
  • Target Price
  • AGX $202.00
  • AMRX $11.50
  • AVG Volume (30 Days)
  • AGX 406.9K
  • AMRX 1.6M
  • Earning Date
  • AGX 09-04-2025
  • AMRX 08-05-2025
  • Dividend Yield
  • AGX 0.67%
  • AMRX N/A
  • EPS Growth
  • AGX 154.06
  • AMRX N/A
  • EPS
  • AGX 7.14
  • AMRX 0.01
  • Revenue
  • AGX $910,157,000.00
  • AMRX $2,852,914,000.00
  • Revenue This Year
  • AGX $10.73
  • AMRX $9.92
  • Revenue Next Year
  • AGX $24.59
  • AMRX $7.39
  • P/E Ratio
  • AGX $31.38
  • AMRX $871.97
  • Revenue Growth
  • AGX 45.08
  • AMRX 9.81
  • 52 Week Low
  • AGX $69.81
  • AMRX $6.69
  • 52 Week High
  • AGX $253.79
  • AMRX $9.59
  • Technical
  • Relative Strength Index (RSI)
  • AGX 49.06
  • AMRX 77.90
  • Support Level
  • AGX $220.51
  • AMRX $7.98
  • Resistance Level
  • AGX $244.12
  • AMRX $8.57
  • Average True Range (ATR)
  • AGX 12.55
  • AMRX 0.28
  • MACD
  • AGX -1.58
  • AMRX 0.15
  • Stochastic Oscillator
  • AGX 21.50
  • AMRX 92.73

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: